1
DURAMED PHARMACEUTICALS, INC.
EXHIBIT (11)
STATEMENT REGARDING COMPUTATION OF EARNINGS PER SHARE
Three months ended Nine months ended
September 30, September 30,
1995 1994 1995 1994
------------------------------ ------------------------------
Primary:
Weighted average common shares
outstanding 8,050,367 7,842,291 8,015,820 7,785,549
Net effect of preferred shares
converted to common shares -
based on the treasury stock
method using the average
market price 746,590 718,854 746,590 710,859
Net effect of dilutive stock
options and warrants - based
on the treasury stock method
using the average market price 1,885,300 1,844,586 1,933,815 1,712,988
----------- ----------- ----------- -----------
Totals 10,682,257 10,405,731 10,696,225 10,209,396
=========== =========== =========== ===========
Net income $ 317,207 $ 1,712,163 $ 1,958,038 $ 4,406,890
=========== =========== =========== ===========
Per share amount $ .03 $ .16 $ .18 $ .43
=========== =========== =========== ===========
Fully diluted:
Weighted average common
shares outstanding 8,050,367 7,842,291 8,015,820 7,785,549
Net effect of preferred shares
converted to common shares -
based on the treasury stock
method using the quarter-end
market price 746,590 727,968 746,590 727,968
Net effect of dilutive stock
options and warrants - based on
the treasury stock method using
the quarter-average market price 1,885,300 2,042,172 1,933,815 2,084,582
----------- ----------- ----------- -----------
Totals 10,682,257 10,612,431 10,696,225 10,598,099
=========== =========== =========== ===========
Net income $ 317,207 $ 1,712,163 $ 1,958,037 $ 4,406,890
=========== =========== =========== ===========
Per share amount $ .03 $ .16 $ .18 $ .42
=========== =========== =========== ===========